ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack tested for Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing a new treatment approach for people with advanced soft tissue sarcomas, including leiomyosarcoma and dedifferentiated liposarcoma. It aims to find the safest dose and best schedule for combining the drug abemaciclib with chemotherapy (gemcitabine). The main …
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First human test of promising new cancer drug combo begins
Disease control Recruiting nowThis early-stage trial is testing whether combining two drugs, zanzalintinib and eribulin, is safe and might help control advanced liposarcoma and leiomyosarcoma. It will enroll 18 adults whose cancer has worsened after at least one prior treatment. The main goal is to find the h…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC